The Series A financing was led by Par Equity to support international expansion and product development.
"Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of paediatric clinical trials. While legislation like RACE, SPCs, and the ODA has increased study numbers, specialist paediatric knowledge is still lacking in the industry. This has led to lower recruitment, adherence and trial completion rates compared to adult research. Little Journey is uniquely positioned to fill this expertise gap and tackle these challenges to advance global paediatric medicine. With the backing of Par Equity, Mercia Ventures, Octopus Ventures, and our wider investor network, we’re redefining how paediatric clinical trials are run and putting families at the heart of them."
The Bath-based sustainable ingredients developer secured backing from Eos Advisory, Progress Tech Transfer, CDP Venture Capital, and Paragon Capital Management.
"Giovanna and her team are tackling one of the most urgent environmental challenges of our time, and we look forward to supporting Naturbeads through its next, exciting phase of commercialisation."
The Series A round was led by Apollo and Motive to expand the alternative asset management platform.
"We have reached an inflection point where alternative asset managers now need their own operating system to power the industry’s next growth phase. We are thrilled to welcome Apollo as an enterprise-scale client and investor as we bring a new standard to the alternative asset management space. We purpose-built Vega AltOS to meet the complex client infrastructure needs of high growth, private markets asset managers. Similar to our experience in the core banking and payments revolution, demand and volumes across all client channels for private markets investments have outstripped the industry’s infrastructure of generic, sub-scale point solutions. We are excited to partner with Apollo and Motive to innovate and solve this industry challenge. Apollo’s contribution of Edna – one of the largest alternative employee investment platforms in the market – accelerates Vega’s AltOS vision for GPs. Edna was incubated at Apollo, in partnership with Motive, and epitomizes the innovative approach to global wealth solutions at Apollo. We are excited to continue expanding our range of GP solutions with the addition of Edna’s employee investment capabilities."
Notion Capital led the Series A round to support Cogna in scaling its AI-powered software development platform across traditional industries.
"Traditional industries have been left behind by the digital revolution due to the complexity of their operational challenges. Cogna’s mission is to empower these sectors with precision software technology that addresses every unique company pain point on its own terms, enabling immediate productivity gains. This funding allows us to bring our technology to more industries and help organisations reduce bottlenecks and free their expert teams from arduous manual tasks, unlocking their vast untapped potential."
The Cambridge semiconductor startup secured backing from Octopus Ventures, Cambridge Innovation Capital, BGF, and Foresight Group.
"Securing this Series A funding underscores the strong confidence our investors have in ForeFront RF’s vision and market potential. With continued support from Foresight Group and BGF, and new partnerships with Octopus Ventures and Cambridge Innovation Capital, we’re well-positioned to scale rapidly from engineering prototypes to mass production."
